Davidson Capital Management Inc. increased its stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 23.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,874 shares of the semiconductor company’s stock after buying an additional 1,124 shares during the quarter. Davidson Capital Management Inc.’s holdings in Synopsys were worth $2,851,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in SNPS. Peloton Wealth Strategists increased its position in shares of Synopsys by 221.2% in the third quarter. Peloton Wealth Strategists now owns 2,881 shares of the semiconductor company’s stock worth $1,459,000 after purchasing an additional 1,984 shares during the period. Swiss National Bank grew its stake in Synopsys by 0.7% during the third quarter. Swiss National Bank now owns 454,800 shares of the semiconductor company’s stock worth $230,306,000 after buying an additional 3,200 shares in the last quarter. Parnassus Investments LLC bought a new position in Synopsys in the 3rd quarter valued at about $633,469,000. Harvest Portfolios Group Inc. lifted its holdings in shares of Synopsys by 3.7% during the 3rd quarter. Harvest Portfolios Group Inc. now owns 42,121 shares of the semiconductor company’s stock worth $21,330,000 after acquiring an additional 1,496 shares during the period. Finally, Nordea Investment Management AB increased its stake in Synopsys by 15.9% in the fourth quarter. Nordea Investment Management AB now owns 1,043,995 shares of the semiconductor company’s stock valued at $509,261,000 after acquiring an additional 143,284 shares during the last quarter. 85.47% of the stock is owned by institutional investors and hedge funds.
Synopsys Stock Down 0.4 %
NASDAQ SNPS opened at $529.14 on Wednesday. The company has a market capitalization of $81.79 billion, a price-to-earnings ratio of 36.44, a PEG ratio of 3.49 and a beta of 1.12. Synopsys, Inc. has a twelve month low of $457.52 and a twelve month high of $629.38. The stock has a fifty day simple moving average of $512.80 and a 200 day simple moving average of $518.34.
Wall Street Analysts Forecast Growth
Read Our Latest Report on Synopsys
Insider Activity
In other news, CRO Richard S. Mahoney sold 20,838 shares of the company’s stock in a transaction on Wednesday, January 15th. The shares were sold at an average price of $506.01, for a total value of $10,544,236.38. Following the sale, the executive now directly owns 1,460 shares of the company’s stock, valued at approximately $738,774.60. This represents a 93.45 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders own 0.66% of the company’s stock.
Synopsys Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Recommended Stories
- Five stocks we like better than Synopsys
- How to Profit From Value Investing
- Broadcom Stock: Why the Upside Is Too Good to Ignore
- Trading Halts Explained
- Citigroup Analysts Are Betting Big on These 3 Stocks—Should You?
- What is the Euro STOXX 50 Index?
- Johnson Controls: 5 Reasons to Own This Engineering Giant
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.